Abstract
Seroreactivity in 130 cases of primary syphilis was 91.5% by fluorescent treponemal antibody absorption test, 82.3% by microhemagglutination (MHA-TP test), and 68.5% by the Venereal Disease Reseach Laboratory (VDRL) test. The MHA TP test generally became reactive earlier than the VDRL test and confirmed all reactive and most weakly reactive VDRL results.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alessi E., Scioccati L. TPHA test. Experience at the Clinic of Dermatology, University of Milan. Br J Vener Dis. 1978 Jun;54(3):151–154. doi: 10.1136/sti.54.3.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jaffe H. W., Larsen S. A., Jones O. G., Dans P. E. Hemagglutination tests for syphilis antibody. Am J Clin Pathol. 1978 Aug;70(2):230–233. doi: 10.1093/ajcp/70.2.230. [DOI] [PubMed] [Google Scholar]
- Logan L. C., Cox P. M. Evaluation of a quantitative automated micro-hemagglutination assay for antibodies to Treponema pallidum. Am J Clin Pathol. 1970 Feb;53(2):163–166. doi: 10.1093/ajcp/53.2.163. [DOI] [PubMed] [Google Scholar]
- Rudolph A. H. The microhemagglutination assay for Treponema pallidum antibodies (MHA-TP), a new treponemal test for syphilis: where does it fit? J Am Vener Dis Assoc. 1976 Sep;3(1):3–8. [PubMed] [Google Scholar]